Mebeverine Tablets And Capsules Suppliers & Bulk Manufacturers
Available Forms: Tablets and capsules
Available Strengths: 135 mg tablets and 200 mg Capsules
Reference Brands: Duspatalin(EU)
Category:
Gastrointestinal Drugs
Mebeverine tablets and capsules are antispasmodics that relax intestinal muscles by inhibiting calcium ions, reducing spasms and cramping. They effectively relieve IBS symptoms, improve bowel function, and decrease abdominal pain. Benefits include symptom relief, enhanced comfort, and improved quality of life for patients with intestinal motility disorders
Mebeverine Tablets and capsules is available in Tablets and capsules
and strengths such as 135 mg tablets and 200 mg Capsules.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Mebeverine Tablets and capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Mebeverine Tablets and capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Mebeverine tablets and capsules, marketed as Duspatalin, are approved in the EU and available as generics. In the US, they are sold as OTC or prescription-only in some formulations. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the EU, EMA guidelines oversee safety and quality, while in the US, FDA regulations apply. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance supports timely approval, safe use, and worldwide availability, aiding patients with irritable bowel syndrome and intestinal spasms across regions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing